re: Ann: Shareholder update Amayapampa, Aust ... Not quite the announcement we were hoping for. It certainly affirms the view that, if Amayapampa doesn't get off the ground, they may as well retire, rather than burning more investor's money.
I'm not sure whether putting all other assests on the market is indicative of expecting a positive bfs. A more likely scenario is that the benefit-cost ratio is coming in tight. By cutting other operating costs and filling the account with the revenue of asset sales would improve the overall company structure and make Amayapampa a more worthwhile project.
I guess its all speculation until we get the numbers...
P.S. to Sentia: it has been a pattern for the years I have followed RAU that you get increased share trading activity a day prior to the ann. So, I would call it a leaky ship.
- Forums
- ASX - By Stock
- BIG
- Ann: Shareholder update Amayapampa, Aust Projects
Ann: Shareholder update Amayapampa, Aust Projects, page-3
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online